Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Aldoxorubicin
Trade Name
Synonyms INNO-206|Doxorubicin-EMCH
Drug Descriptions

Aldoxorubicin (Doxorubicin-EMCH) is a derivative prodrug of doxorubicin that is converted to free doxorubicin within the acidic environment within tumors, and once converted, doxorubicin intercalates DNA, inhibits DNA synthesis and induces apoptosis (PMID: 30936721).

DrugClasses Chemotherapy - Anthracycline 13
CAS Registry Number 151038-96-9
NCIT ID C68921

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Abexinostat + Aldoxorubicin Abexinostat Aldoxorubicin 0 0
Aldoxorubicin Aldoxorubicin 0 5
Aldoxorubicin + Alvocidib Aldoxorubicin Alvocidib 0 0
Aldoxorubicin + Avelumab + Bevacizumab + Capecitabine + Cyclophosphamide + ETBX-011 + ETBX-021 + ETBX-051 + ETBX-061 + Fluorouracil + Gemcitabine + GI-4000 + GI-6207 + GI-6301 + haNK cells + Leucovorin + Nab-paclitaxel + Nogapendekin alfa inbakicept + Oxaliplatin Aldoxorubicin Avelumab Bevacizumab Capecitabine Cyclophosphamide ETBX-011 ETBX-021 ETBX-051 ETBX-061 Fluorouracil GI-4000 GI-6207 GI-6301 Gemcitabine Leucovorin Nab-paclitaxel Nogapendekin alfa inbakicept Oxaliplatin haNK cells 0 2
Aldoxorubicin + Avelumab + Capecitabine + Cetuximab + Cyclophosphamide + ETBX-011 + ETBX-021 + ETBX-051 + ETBX-061 + Fluorouracil + GI-4000 + GI-6207 + GI-6301 + haNK cells + Leucovorin + Nab-paclitaxel + Nogapendekin alfa inbakicept + Oxaliplatin + Regorafenib + Trastuzumab Aldoxorubicin Avelumab Capecitabine Cetuximab Cyclophosphamide ETBX-011 ETBX-021 ETBX-051 ETBX-061 Fluorouracil GI-4000 GI-6207 GI-6301 Leucovorin Nab-paclitaxel Nogapendekin alfa inbakicept Oxaliplatin Regorafenib Trastuzumab haNK cells 0 1
Aldoxorubicin + Avelumab + Capecitabine + Cetuximab + Cyclophosphamide + ETBX-011 + ETBX-051 + ETBX-061 + Fluorouracil + GI-4000 + GI-6207 + GI-6301 + haNK cells + Leucovorin + Nab-paclitaxel + Nogapendekin alfa inbakicept + Sorafenib Aldoxorubicin Avelumab Capecitabine Cetuximab Cyclophosphamide ETBX-011 ETBX-051 ETBX-061 Fluorouracil GI-4000 GI-6207 GI-6301 Leucovorin Nab-paclitaxel Nogapendekin alfa inbakicept Sorafenib haNK cells 0 1
Aldoxorubicin + Avelumab + Cetuximab + ETBX-051 + ETBX-061 + GI-6301 + haNK cells + Nogapendekin alfa inbakicept Aldoxorubicin Avelumab Cetuximab ETBX-051 ETBX-061 GI-6301 Nogapendekin alfa inbakicept haNK cells 0 1
Aldoxorubicin + Avelumab + Cisplatin + Cyclophosphamide + ETBX-011 + ETBX-051 + ETBX-061 + Fluorouracil + GI-4000 + GI-6301 + haNK cells + Nogapendekin alfa inbakicept + Paclitaxel Aldoxorubicin Avelumab Cisplatin Cyclophosphamide ETBX-011 ETBX-051 ETBX-061 Fluorouracil GI-4000 GI-6301 Nogapendekin alfa inbakicept Paclitaxel haNK cells 0 1
Aldoxorubicin + Avelumab + Cyclophosphamide + ETBX-011 + ETBX-051 + ETBX-061 + Fluorouracil + GI-4000 + GI-6207 + GI-6301 + haNK cells + Leucovorin + Nab-paclitaxel + Nogapendekin alfa inbakicept Aldoxorubicin Avelumab Cyclophosphamide ETBX-011 ETBX-051 ETBX-061 Fluorouracil GI-4000 GI-6207 GI-6301 Leucovorin Nab-paclitaxel Nogapendekin alfa inbakicept haNK cells 0 1
Aldoxorubicin + B02 Aldoxorubicin B02 0 0
Aldoxorubicin + Bendamustine + Bortezomib Aldoxorubicin Bendamustine Bortezomib 0 0
Aldoxorubicin + Buparlisib Aldoxorubicin Buparlisib 0 0
Aldoxorubicin + Cisplatin + Cyclophosphamide + Dexamethasone + Etoposide Aldoxorubicin Cisplatin Cyclophosphamide Dexamethasone Etoposide 0 1
Aldoxorubicin + Cisplatin + Filgrastim + Methotrexate + Vinblastine Aldoxorubicin Cisplatin Filgrastim Methotrexate Vinblastine 0 1
Aldoxorubicin + Cisplatin + Methotrexate + Vincristine Sulfate Aldoxorubicin Cisplatin Methotrexate Vincristine Sulfate 0 1
Aldoxorubicin + Cyclophosphamide + Gemcitabine + Nab-paclitaxel Aldoxorubicin Cyclophosphamide Gemcitabine Nab-paclitaxel 0 0
Aldoxorubicin + Cyclophosphamide + Gemcitabine + Nab-paclitaxel + Nogapendekin alfa inbakicept Aldoxorubicin Cyclophosphamide Gemcitabine Nab-paclitaxel Nogapendekin alfa inbakicept 0 1
Aldoxorubicin + Cyclophosphamide + Gemcitabine + Nab-paclitaxel + Nogapendekin alfa inbakicept + PD-L1.t-haNK cells Aldoxorubicin Cyclophosphamide Gemcitabine Nab-paclitaxel Nogapendekin alfa inbakicept PD-L1.t-haNK cells 0 1
Aldoxorubicin + Cyclophosphamide + Prednisone + Rituximab + Vincristine Sulfate Aldoxorubicin Cyclophosphamide Prednisone Rituximab Vincristine Sulfate 0 1
Aldoxorubicin + Cyclophosphamide + Veliparib Aldoxorubicin Cyclophosphamide Veliparib 0 1
Aldoxorubicin + Dactolisib Aldoxorubicin Dactolisib 0 0
Aldoxorubicin + Docetaxel + Estramustine + Ketoconazole Aldoxorubicin Docetaxel Estramustine Ketoconazole 0 1
Aldoxorubicin + Durvalumab + Motolimod Aldoxorubicin Durvalumab Motolimod 0 1
Aldoxorubicin + Ganetespib Aldoxorubicin Ganetespib 0 1
Aldoxorubicin + Metformin Aldoxorubicin Metformin 0 0
Aldoxorubicin + Rigosertib Aldoxorubicin Rigosertib 0 0
Aldoxorubicin + Seliciclib Aldoxorubicin Seliciclib 0 0


Additional content available in CKB BOOST